Literature DB >> 27769513

[Surgical management of ovarian cancer: Trends in clinical practice].

Denis Querleu1, Jacques Meurette2, Emile Daraï3, Philippe Morice4, François Planchamp5.   

Abstract

Surgery has evolved as a mainstay of the management of ovarian cancer since evidence of the major benefit of complete surgery, i.e. achieving complete resection of the disease without visible macroscopic residue in a comprehensively explored abdominal cavity, has been made available. This objective may be difficult to complete in case of advanced ovarian cancer, as it requires the use of advanced techniques of peritoneal and visceral surgery, in the setting of adapted perioperative care, generally in institutions where the caseload is sufficient to ensure an appropriate surgical experience, and where specifically trained surgeons are available. In this paper using the data from the French national database PMSI, evidence of an evolution of the proportion of patients managed in centers where more than 20 patients a year are operated is shown. However, the recommendations of the governmental Plans Cancers are far from universally implemented. Copyright Â
© 2016 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cancers de l’ovaire; Chirurgie; Contrôle qualité; Ovarian cancer; Quality assurance; Surgery

Mesh:

Year:  2016        PMID: 27769513     DOI: 10.1016/j.bulcan.2016.09.013

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  2 in total

1.  MicroRNA-138 inhibits SOX12 expression and the proliferation, invasion and migration of ovarian cancer cells.

Authors:  Miaomiao Qu; Yongning Zhu; Meng Jin
Journal:  Exp Ther Med       Date:  2018-06-29       Impact factor: 2.447

2.  Adherence to French and ESGO Quality Indicators in Ovarian Cancer Surgery: An Ad-Hoc Analysis from the Prospective Multicentric CURSOC Study.

Authors:  Martinez Alejandra; Witold Gertych; Christophe Pomel; Gwenael Ferron; Amelie Lusque; Martina Aida Angeles; Eric Lambaudie; Roman Rouzier; Naoual Bakrin; Francois Golfier; Olivier Glehen; Michel Canis; Nicolas Bourdel; Nicolas Pouget; Pierre-Emmanuel Colombo; Frédéric Guyon; Jacques Meurette; Denis Querleu
Journal:  Cancers (Basel)       Date:  2021-03-30       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.